who is developing retatrutide – The New Weight Loss Helper Retatrutide a new medication being developed by Eli Lilly to help people lose weight. It's like a super version of drugs such as Ozempic who is developing retatrutide Retatrutide
Description
Others extend to 20+ weeks
Results from the TRIUMPH-1 Phase 3 trial show participants on 9mg losing an average of 23.7% of body weight, and those on 12mg losing 25% at 80 weeks overall with the subgroup of participants escalated to maximum tolerated dose achieving the full 28.3% Synedica Retatrutide weight loss result
Recently, in a phase 1 clinical study, AMG133 demonstrated a pronounced dose-dependent weight loss in participants with obesity
In the tables below we keep each peptide in whichever unit its protocol page uses, but the computed columns normalise everything so the syringe units are directly comparable
Amy Janke, E
